Stuart Therapeutics, Inc. Appoints Dave LeCause as Senior Commercial Advisor
-
September 18, 2026
-
2 min
September 18, 2026
Senju Pharmaceutical launches the first TRPV1 antagonist for dry eye in Japan
April 30, 2026
Expert consensus aims to set professional standards for the use of AI in dry eye diagnosis, monitoring, and personalized treatment
June 29, 2026
The trilayer decellularized basement membrane is used in ocular surgery and in OSD applications, including corneal and conjunctival-related injuries or defects.
May 1, 2026